Medical and Science
First female president of the Cardiac Society of Australia and New Zealand
The Cardiac Society of Australia and New Zealand (CSANZ) is pleased to announce the appointment of Professor Clara Chow as President-elect. Clara will be the CSANZ’s first female President, her term in office commencing in August 2020.
Clara Chow is Professor of the Faculty of Medicine and Health at the University of Sydney and is Academic Director of the Westmead Applied Medical Research Centre and Program Director Community Based Cardiac Services and Cardiologist at Westmead Hospital, Sydney.
The Cardiac Society of Australia and New Zealand is the professional body for cardiologists and those working in the area of cardiology including researchers, scientists, cardiovascular nurses, allied health professionals and other healthcare workers. The Society is established with the object of promoting the highest standards of education, training, research and practice in cardiovascular medicine and surgery as well as promoting the prevention and control of cardiovascular disease in human beings.
CSANZ President, Professor Len Kritharides, said “The CSANZ is very fortunate to have Clara as its incoming President. She is an outstanding Cardiologist and Researcher and will bring great energy and insight to the role.”
Professor Chow said “I am excited and proud to take up the President-elect position of the Cardiac Society of Australia and New Zealand. I think this shows the strong commitment of our society to change and addressing the challenges of diversity for our members as well as our patients.”
Prof Chow will serve as President-elect for 12 months and will take up the role of President in August, 2020.
You may also like Therapeutics and the importance of cancer research in Australia
News & Trends - Pharmaceuticals
Government inaction on mental illness faces overwhelming criticism ahead of federal election
Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]
MoreNews & Trends - Pharmaceuticals
New CVD model marks a critical step in the right direction
Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]
MoreNews & Trends - Pharmaceuticals
Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation
Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]
MoreLeadership & Management
J&J MedTech appoints new ANZ leader
Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]
More